Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Non-Current Assets for 9 consecutive years, with $323.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 82.27% to $323.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $933.0 million through Dec 2025, up 49.02% year-over-year, with the annual reading at $323.7 million for FY2025, 82.27% up from the prior year.
  • Non-Current Assets hit $323.7 million in Q4 2025 for Inspire Medical Systems, up from $221.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $323.7 million in Q4 2025 to a low of $12.6 million in Q1 2021.
  • Historically, Non-Current Assets has averaged $100.8 million across 5 years, with a median of $64.0 million in 2023.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 440.81% in 2021 and later grew 3.53% in 2025.
  • Year by year, Non-Current Assets stood at $26.5 million in 2021, then soared by 31.25% to $34.8 million in 2022, then skyrocketed by 138.41% to $83.1 million in 2023, then skyrocketed by 113.76% to $177.6 million in 2024, then surged by 82.27% to $323.7 million in 2025.
  • Business Quant data shows Non-Current Assets for INSP at $323.7 million in Q4 2025, $221.2 million in Q3 2025, and $229.0 million in Q2 2025.